Israeli pharmaceutical giant Teva has announced that the American Food and Drugs Administration (FDA) has granted approval for Synribo, an injectable drug for treating leukemia. The company says that the drug will soon be available for prescription.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments